Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06456463
Title A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stemline Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS


No variant requirements are available.